MAMahmood Thamer Altemimi

Mahmood Thamer Altemimi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mahmood Thamer Altemimi has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endocrine dysfunctions in patients with beta thalassemia major: a single-center retrospective study from Basrah

    by Haider Alidrisi, Hussein Nwayyir, Mahmood Altemimi, Nassar Alibrahim, Ola Hamid, Israa Abdulbari, Nargis Noman, Abbas Mansour

    * Background The management of patients with beta thalassemia major (BTH) involves regular blood transfusions which are associated with iron overload. This may result in various endocrine dysfunctions (EDs). This study aimed to assess the obesrved frequency of different EDs in patients with transfusion-dependent BTH. Method A retrospective study that included 496 patients with BTH who were referred from the Basra Center for hereditary blood diseases to Faiha Specialized Diabetes, Endocrine and Metabolsim Center for endocrine-related complaints and underwent detailed endocrine assessments from Jan 2010 to Dec 2023. Results The mean presentation age for endocrine evaluation was 13.6 ± 6.5 years with no difference between male and female. The commonest clinical presentations of BTH patients in our center were short stature 65.5%, amenorrhea 16.4, hyperglycemia 13.7%, delayed puberty 13.3, and hypocalcemia 5.2%. The proportion patients with ED was 16.8%. The most frequent EDs were growth hormone deficiency (GHD) 6.0%, diabetes mellitus (DM) 4.9%, hypogonadism 4.5%, hypothyroidism 3.2%. Within those patients, 78.7% had single ED, 16.5% had two EDs and 4.8% had three or more EDs. Conclusion EDs were observed among patients with BTH. The commonest EDs were GHD, DM, and hypogonadism. We recommend regular and timely surveillance using both clinical and hormonal assessment in patients with BTH.

  • Open Access

    Endocrine dysfunctions in patients with beta thalassemia major: a single-center retrospective study from Basrah

    by Haider Alidrisi, Hussein Nwayyir, Mahmood Altemimi, Nassar Alibrahim, Ola Hamid, Israa Abdulbari, Nargis Noman, Abbas Mansour

    * Background The management of patients with beta thalassemia major (BTH) involves regular blood transfusions which are associated with iron overload. This may result in various endocrine dysfunctions (EDs). This study aimed to assess the prevalence of different EDs in patients with BTH. Method A retrospective study that included 496 patients with BTH who were referred from the Basra Center for hereditary blood diseases to Faiha Specialized Diabetes, Endocrine and Metabolsim Center for endocrine-related complaints and underwent detailed endocrine assessments from Jan 2010 to Dec 2023. Results The mean presentation age for endocrine evaluation was 13.6 ± 6.5 years with no difference between male and female. The commonest clinical presentations of BTH patients in our center were short stature 65.5%, amenorrhea 16.4, hyperglycemia 13.7%, delayed puberty 13.3, and hypocalcemia 5.2%. The prevalence of ED was 16.8%. The most frequent EDs were growth hormone deficiency (GHD) 6.0%, diabetes mellitus (DM) 4.9%, hypogonadism 4.5%, hypothyroidism 3.2%. Within those patients, 78.7% had single ED, 16.5% had two EDs and 4.8% had three or more EDs. Conclusion EDs were prevalent in patients with BTH. The commonest EDs were GHD, DM, and hypogonadism. These findings explore the importance of regular and timely surveillance using both clinical and hormonal assessment in patients with BTH.

  • Open Access

    Assessing the Features of Diabetic Foot Ulcers among Individuals with Type 2 Diabetes Mellitus in Thi Qar, Iraq

    by Adel Gassab Mohammed, Dheyaa Kadhim Al-Waeli, Samih Abed Odhaib, Mahmood Thamer Altemimi

    Background This study aimed to evaluate the characteristics of diabetic foot ulcers in individuals with type 2 diabetes mellitus (T2DM) in Iraq. Methods The study included 881 participants with T2DM and different types of foot ulcers, who attended a specialized diabetes center. Data on demographics, clinical characteristics, biochemical investigations, comorbidities, and treatment regimens were collected and analyzed. Results The majority of the cases (96.8%) were due to T2DM, with an average age of 58 years and a mean BMI of 30 kg/m 2 . Participants had elevated serum creatinine, blood urea, and glucose levels, with uncontrolled HbA1c levels. Comorbidities included hypertension, ischemic heart disease, diabetic neuropathy, and retinopathy. Most participants were on insulin and statins. Diabetic foot ulcers were mainly on the right foot (48%) and classified as Grade 2 in Wagner’s system. Some participants had Charcot deformity or stages of amputation. Conclusions Random plasma glucose levels and diabetic retinopathy were significantly associated with the classification of foot ulcers. Further research is needed to explore additional variables related to T2DM and foot ulcers, emphasizing the importance of glucose control and retinopathy in ulcer classification.


  • Open Access

    Thyroid nodules stratification by American Thyroid Association and American College of Radiology lexicons: Thi-qar study

    by Dheyaa Kadhim Al-Waeli, Adel Gassab Mohammed, Samih Abed Odhaib, Mahmood Thamer Altemimi, Shakir Aglah Khalifa, Israa Ali Hasan, Mohammed Uday Hatim, Imad Hatim Tahir

    The diagnostic performance of sonography to manage thyroid nodule (TN) may influence excess biopsy in different clinical settings. American College of Radiology (ACR) presented Thyroid Imaging Reporting and Data Systems (TIRADS) lator to American Thyroid Association (ATA) risk stratification guidelines, with variable diagnostic performance. The objective of this study is to evaluate the effectiveness of ACR-TIRADS versus ATA lexicons for thyroid cancer prediction among individuals with TN in Thi-Qar, Iraq. This cross-sectional observational study enrolled 1,007 individuals aged ≥ 14 years with 1,155 TNs attending a tertiary endocrine center. Malignancy risk was classified using both ACR-TIRADS and ATA lexicons with matched categories: TIRAD-1 (Benign<1%), TIRAD-2 (Very Low<3%), (TIRAD-3 (Low 5-10%), (TIRAD-4 (Intermediate 10-20%), and (TIRAD-5 (High 70-90%). Fine needle aspiration (FNAC) and histopathological diagnosis were made according to the Bethesda system and agreement between lexicons was assessed using sensitivity, specificity, Cohen’s Kappa Statistics, and McNemar test. Among participants, 85.2% were women, with mean age 46±14 years. Most individuals were euthyroid (71%), TNs were located in right lobe (51.3%), left lobe (42.5%), and isthmus (6.1%). FNAC was indicated for 54.6% of TNs by ATA and 44.6% by ACR-TIRADS criteria. High-risk cytology (Bethesda IV-V) was 7.1% and ATA system demonstrated higher sensitivity (74.3%) and accuracy (58.6%) than ACR-TIRADS (sensitivity 60%, accuracy 53%), though both gave modest diagnostic performance and low positive predictive values (<12%). Agreement between systems was weak (Cohen’s κ=0.265±0.032, p < 0.001), with concordance in 50.1% of cases. Both risk stratification systems had comparable but modest diagnostic performance. ATA identified more FNAC-eligible TNs with slightly higher sensitivity, specificity, prediction, and overall accuracy. However, the weak agreement between raters highlights variability in nodule categorization and management, supporting the need to integrate sonographic findings with clinical and biochemical factors to optimize TNs evaluation and minimize unnecessary biopsies.


  • Quality of Life in Polycystic Ovary Syndrome after Anti-Androgen Therapy Using PCOSQOL-47 and PCOSQOL-42

    by Samih Abed Odhaib, Mahmood Thamer Altemimi, Adel Gassab Mohammed, Dheyaa Kadhim Al-Waeli, Miaad Jassim Mohammed, Haider Ayad Alidrisi, Husam Jihad Imran, Abbas Ali Mansour

    Introduction: Hyperandrogenism in Polycystic ovary syndrome (PCOS) negatively affects health-related quality of life (HRQOL). Anti-androgens may improve both biochemical and patient-related outcomes. Objectives: To evaluate the impact of combined finasteride and spironolactone on HRQOL in married and unmarried women with PCOS using PCOSQOL-47 and PCOSQOL-42, respectively. Methods: A total of 263 married and 236 unmarried women with PCOS were enrolled from two tertiary centers. All received finasteride (5mg) and spironolactone (100mg) daily and were followed every four months over a year. HRQOL was assessed using PCOSQOL-47 for married and PCOSQOL-42 for unmarried women, alongside evaluating their biochemical and clinical hyperandrogenism. Results: After one year, significant reductions were observed in total and free testosterone, dehydroepiandrosterone sulfate, body mass index (BMI), and a decrease in modified Ferriman-Gallwey (mFG) scores. Both groups showed marked HRQOL improvement, greater in unmarried women. In PCOSQOL-47, psychological and emotional domains improved most, while fertility and sexual domains improved least. In PCOSQOL-42, menstrual and fertility domains had the highest gains, while coping improved least. Both groups had a 25% reduction in mFG score and 5% reduction in BMI. Discussion: This is the first study to evaluate combined finasteride and spironolactone on HRQOL domains in PCOS using PCOSQOL-47 and PCOSQOL-42. Prior studies assessing anti- androgens used other tools, without distinction between married and unmarried women. Conclusions: Combined finasteride and spironolactone significantly improved all HRQOL scales and reduced hyperandrogenism within the first four months in women with PCOS, supporting its role alongside lifestyle measures.

  • Open Access

    Assessing the Features of Diabetic Foot Ulcers among Individuals with Type 2 Diabetes Mellitus in Thi Qar, Iraq

    by Adel Gassab Mohammed, Dheyaa Kadhim Al-Waeli, Samih Abed Odhaib, Mahmood Thamer Altemimi

    Background This study aimed to evaluate the characteristics of diabetic foot ulcers in individuals with type 2 diabetes mellitus (T2DM) in Iraq. Methods The study included 881 participants with T2DM and different types of foot ulcers, who attended a specialized diabetes center. Data on demographics, clinical characteristics, biochemical investigations, comorbidities, and treatment regimens were collected and analyzed. Results The majority of the cases (96.8%) were due to T2DM, with an average age of 58 years and a mean BMI of 30 kg/m 2 . Participants had elevated serum creatinine, blood urea, and glucose levels, with uncontrolled HbA1c levels. Comorbidities included hypertension, ischemic heart disease, diabetic neuropathy, and retinopathy. Most participants were on insulin and statins. Diabetic foot ulcers were mainly on the right foot (48%) and classified as Grade 2 in Wagner’s system. Some participants had Charcot deformity or stages of amputation. Conclusions Random plasma glucose levels and diabetic retinopathy were significantly associated with the classification of foot ulcers. Further research is needed to explore additional variables related to T2DM and foot ulcers, emphasizing the importance of glucose control and retinopathy in ulcer classification.

  • Open Access

    The Predominant Risk Factors for the Development of Gestational Diabetes Mellitus among Reproductive Age Women from Thi-Qar

    by Farhan Gafel, Md, Majid Abdulwahab Maatook, Ph.D, Mahmood Thamer Altemimi, Noor

    Gestational diabetes mellitus (GDM), a prevalent illness, describes maternal glucose intolerancethat is first discovered during pregnancy. There are multiple risk factors linked to the developmentof GDM. Aim of study: to evaluate which risk factors are most common for the development ofGDM in Thi-Qar's reproductive-age women, and to predict which risk factors have the worstoutcomes for both the mother and fetus. Methodology: A cross-sectional observational study wasconducted on 1504 reproductive-age married women attending an Endocrine Center. All patients’data were collected from direct interviewees and the use of digital records of the tertiary center,which used an internal network system and the Microsoft Access program. Demographiccharacteristics and Clinical history of GDM, history of macrosomia, and family history of diabeteswere documented. Results: The mean age of participant was 33 ±8 years old, their mean weightwas 76 ±15 kg, their BMI was 30.8±5.7 (Kg/m2), and their waist circumference was 94.5±12.5centimeters. BMI, first-degree relatives with diabetes, chronic hypertension, macrosomia,polycystic ovary syndrome, and lipid disorder were significantly higher among women with GDMrather than those without (p-value = 0.004, 0.001, 0.001, 0.001, 0.001, 0.001, respectively).Conclusion: Family history of DM, obesity, macrosomia, PCOS, hypertension, lipid disorder,multiparity, and number of stillbirths are measured as dependent risk factors for the prediction ofGDM and DM complications. Heart disease, kidney disease, congenital anomalies, and physicalinactivity were insignificant associations with the incidence of GDM in this study. GDM isconsidered another risk factor for the prediction of chronic DM and later complications

  • Open Access

    Sexual dysfunction in women with newly diagnosed thyroid dysfunction: a novel report from Basrah, Iraq

    by Samih Abed Odhaib, Mahmood Thamer Altemimi, Abbas Ali Mansour

    Thyroid dysfunction has been proposed as a potential contributor to Female Sexual Dysfunction (FSD), yet its impact, particularly in subclinical and autoimmune forms, remains controversial, especially in culturally conservative populations. This study aimed to assess the relationship between newly diagnosed thyroid dysfunction and sexual function among married, premenopausal women in Basrah, Iraq, using the Arabic version of the Female Sexual Function Index (FSFI). Out of 673 women aged 20–48 years presenting with sexual complaints, 229 with clinically confirmed FSD were enrolled. Of these, 42 were newly diagnosed with thyroid dysfunction, either overt or subclinical, autoimmune or non-autoimmune, and served as the case group. In contrast, 187 women with normal thyroid function served as controls. Hormonal profiling included Thyroid- Stimulating Hormone (TSH), Free Thyroxine (FT4), total testosterone (TT), Sex Hormone-Binding Globulin (SHBG), Calculated Free Testosterone (cFT), Estradiol (E2), and Prolactin (PRL). FSFI domain scores and hormonal parameters were compared across groups and subgroups. Subclinical and overt thyroid dysfunction were identified in 8.3% and 10.04% of the cohort, respectively. FSFI scores were significantly low across all domains in both groups. Although the orgasm domain (p=0.043) and total FSFI score (p=0.020) showed statistical significance, the overall clinical impact was limited due to the uniformly low scores. Hormonal levels, including PRL, TT, SHBG, cFT, and E2, did not differ significantly between groups, except for higher E2 levels among women with autoimmune thyroid dysfunction (p=0.026). No significant differences in FSFI scores were observed between autoimmune and non-autoimmune groups, or between autoimmune hypothyroidism and autoimmune hyperthyroidism. These findings suggest that thyroid dysfunction, whether overt, subclinical, or autoimmune, does not appear to be a major determinant of FSD in this population. The results support a multifactorial origin of FSD and underscore the need for culturally sensitive, interdisciplinary approaches to better understand and manage sexual health concerns among women in conservative societies.


  • Open Access

    The Performance of the American Thyroid Association (ATA) and American College of Radiology (ACR-TIRAD) Thyroid Nodule Risk-Stratification Systems in Determining High-Risk Nodules, and the Correlation of Site, Size, and Autoimmunity with High-Risk Features

    by Ibrahim H. Hussein, Mahmood T. Altemimi, Haider A. Alidrisi, Ammar M. Saeed Almomin, Nassar T. Alibrahim, Muqdam A. Hamza, Husam J. Imran, Ibrahim A. Zaboon, Ali H. Alhamza, Hussein A. Nwayyir, et al.

    Introduction: Neck ultrasonography (US) and fine-needle aspiration (FNA) biopsy are usually used to evaluate thyroid nodules. This study aimed to evaluate the performance of two popular thyroid imaging reporting systems in detecting thyroid malignancy and to evaluate the correlation between thyroid autoimmunity, nodule site, and size in the development of malignancy. Methods: This prospective study was conducted from January 2019 to July 2021 in Basrah, Iraq. The American Thyroid Association (ATA) and American College of Radiology-Thyroid Imaging Reporting and Data (ACR-TIRAD) systems were used to evaluate the malignant potential of 143 thyroid nodules in 131 patients. Results: The sensitivity and positive predictive value (PPV) of the ATA system for detecting malignancy were 96% and 20.8% for low-risk and 100% and 4.3% for high-risk nodules, respectively. ACR-TIRAD sensitivity and PPV were 84% and 22.1% for low-risk and 80% and 4.2% for high-risk nodules, respectively. The specificity and negative predictive value (NPV) of the ATA system for detecting malignancy were 11.6% and 92.3% for low-risk and 10.5% and 100% for high-risk nodules, respectively. The ACR-TIRAD specificity and NPV were 28% and 87.8% for low-risk and 26% and 96.9% for high-risk nodules, respectively. The strength of the correlation between FNA performed across different Bethesda categories and age, sex, nodule size, and positive thyroid peroxidase (TPO) antibodies were 0.25, 0.01, 0.22, and 0.4, respectively. Conclusion: Both systems are effective; however, adopting TI-RADS stratification results in fewer biopsies being performed for thyroid nodule assessment. Only sex was found to be significantly correlated with FNA performance in thyroid-nodule evaluation.


  • Open Access

    Barriers to Insulin Initiation for Patients with Type 2 Diabetes: A Cross-Sectional Study in Thi-Qar Province, Southern Iraq

    by Adel Gassab Mohammed, Riyadh Khion Abdulah, Samih Abed Odhaib, Dheya Kadhim AlWaeli, Mahmood Thamer Altemimi

    Type 2 diabetes mellitus (T2DM) poses a significant economic and clinical burden. Clinical inertia is defined as the failure of healthcare providers to modify therapy in the presence of clear indications. This study aimed to identify patient opinions on insulin to understand the barriers preventing type 2 diabetes patients from initiating insulin treatment when recommended by their physician. This cross-sectional observational study included 671 individuals with poorly controlled T2DM and HbA1c levels exceeding 10%. These patients required either the initiation or escalation of their existing insulin therapy. The participants were referred to Thi-Qar Specialized Diabetes Endocrine and Metabolism Center (TDEMC) for consultation between January 2022 and July 2022.Results: During discussions between the researcher (clinician) and the inadequately controlled T2DM patients, the primary reasons for refusing insulin therapy were identified. These reasons included fear of injections, the belief that insulin induces dependence and is a last resort, concerns about hypoglycemia and complications, cost, difficulty in computing doses, social stigma, inconvenience and disruption to life and work, storage challenges, fear of weight gain, dependence on others, and lack of confidence.The study concludes that the clinical barriers faced by individuals who refuse the initiation of insulin therapy are diverse. The most common belief among the patients was that insulin leads to dependence (38%), while the smallest percentage cited a lack of confidence in insulin as an effective treatment for lowering hyperglycemia.